Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
nicholas.crump@ndcls.ox.ac.uk

Research groups

Milne Group: Epigenetics and Gene Regulation in Leukaemia

Nicholas Crump

Postdoctoral researcher

Recent publications

BET inhibition disrupts transcription but retains enhancer-promoter contact.
Journal article

Crump NT. et al, (2021), Nat Commun, 12
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.
Journal article

Godfrey L. et al, (2021), Leukemia, 35, 90 - 106
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs.
Journal article

O'Byrne S. et al, (2019), Blood, 134, 1059 - 1071
Why are so many MLL lysine methyltransferases required for normal mammalian development?
Journal article

Crump NT. and Milne TA., (2019), Cell Mol Life Sci, 76, 2885 - 2898
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation.
Journal article

Godfrey L. et al, (2019), Nat Commun, 10

More publications